PracaRelacje InwestorskieCOVID-19
  1. Siemens Healthineers Polska
  2. Point-of-Care Testing
  3. Rozwiązania do szybkich badań parametrów kardiologicznych
  4. Testy kardiologiczne
  5. NT-proBNP

NT-proBNPHelping to identify the severity of congestive heart failure and risk stratification of acute coronary syndrome

The Stratus® CS Acute Care™ NT-proBNP assay is an in vitro diagnostic test for the quantitative measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP) in heparinized plasma. In individuals suspected of having CHF, measurements of NT-proBNP are used as an aid in diagnosis and the assessment of severity. The test is further indicated for the risk stratification of patients with acute coronary syndrome and heart failure, resulting from left-ventricular dysfunction.

  • One sample, one run, one instrument; increased efficiency in triaging chest pain patients
  • Rapid turnaround time - in as little as 14 minutes (with on-board centrifugation)
  • Single and ready to use TestPaks™ Cartridges. No reconstitution. No warming to room temperature. Reduction in reagent waste
  • Aid in diagnosing individuals suspected of having congestiv heart failure (CHF)
NT-proBNP
NT-proBNP

Cechy i korzyści

  • One sample, one run, one instrument; increases efficiency in triaging chest pain patients
  • Rapid turnaround time - in as little as 14 minutes (with onboard centrifugation)
  • Single and ready to use TestPak™ Cartridges
             o No reconstitution
             o No warming to room temperature
             o Reduction in reagent waste
             o Reduction in contamination
  • Heparinized whole blood samples
  • Electronic QC (System Check) satisfies daily routine QC requirements permitting liquid QC flexibility 

 

Zastosowanie kliniczne

Measurements of NT-proBNP are used as an aid in the diagnosis of individuals suspected of having congestive heart failure (CHF). Other potential clinical uses of NT-proBNP are risk stratification of patients with acute coronary syndrome (ACS) and CHF, as well as treatment and monitoring in patients with left ventricular dysfunction (LVD).

Specyfikacje techniczne

NT-proBNP

Assay Range

15 – 20,000 pg/mL

Sensitivity

15.0 pg/mL

Reproducibility (CV)

4.4% at 96.6 pg/mL

Calibration Stability

30 days

DilPak™ Automatic Dilution

Yes

Sodium Heparin Tubes

Yes

Lithium Heparin Tubes

Yes